Tyers Asset Management LLC boosted its stake in UnitedHealth Group Inc (NYSE:UNH) by 19.4% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 171,732 shares of the healthcare conglomerate’s stock after acquiring an additional 27,918 shares during the period. UnitedHealth Group accounts for 1.4% of Tyers Asset Management LLC’s investment portfolio, making the stock its 9th largest holding. Tyers Asset Management LLC’s holdings in UnitedHealth Group were worth $42,133,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently made changes to their positions in UNH. Ballentine Partners LLC lifted its stake in UnitedHealth Group by 2.3% in the second quarter. Ballentine Partners LLC now owns 9,038 shares of the healthcare conglomerate’s stock valued at $2,218,000 after buying an additional 202 shares during the period. Nikulski Financial Inc. lifted its stake in UnitedHealth Group by 1.8% in the second quarter. Nikulski Financial Inc. now owns 11,759 shares of the healthcare conglomerate’s stock valued at $2,885,000 after buying an additional 205 shares during the period. Trustcore Financial Services LLC lifted its stake in UnitedHealth Group by 34.1% in the second quarter. Trustcore Financial Services LLC now owns 810 shares of the healthcare conglomerate’s stock valued at $199,000 after buying an additional 206 shares during the period. Lara May & Associates LLC lifted its stake in UnitedHealth Group by 22.2% in the first quarter. Lara May & Associates LLC now owns 1,146 shares of the healthcare conglomerate’s stock valued at $246,000 after buying an additional 208 shares during the period. Finally, Liberty Capital Management Inc. lifted its stake in UnitedHealth Group by 1.3% in the second quarter. Liberty Capital Management Inc. now owns 15,739 shares of the healthcare conglomerate’s stock valued at $3,861,000 after buying an additional 209 shares during the period. Institutional investors and hedge funds own 85.39% of the company’s stock.

Several equities analysts have issued reports on UNH shares. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $278.00 price target on the stock in a research note on Wednesday, May 23rd. BMO Capital Markets boosted their price target on UnitedHealth Group from $275.00 to $285.00 and gave the company a “buy” rating in a research note on Thursday, June 7th. SunTrust Banks began coverage on UnitedHealth Group in a research note on Monday, June 11th. They issued a “buy” rating and a $300.00 price target on the stock. Cantor Fitzgerald reaffirmed a “buy” rating and set a $300.00 target price on shares of UnitedHealth Group in a research report on Thursday, July 5th. Finally, Goldman Sachs Group reaffirmed a “buy” rating and set a $277.00 target price on shares of UnitedHealth Group in a research report on Tuesday, July 17th. Two research analysts have rated the stock with a hold rating and twenty-one have given a buy rating to the company’s stock. UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $272.43.

In related news, CEO Steven H. Nelson sold 26,033 shares of the stock in a transaction on Friday, September 7th. The stock was sold at an average price of $270.65, for a total value of $7,045,831.45. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director William C. Ballard, Jr. sold 10,000 shares of the stock in a transaction on Wednesday, August 8th. The shares were sold at an average price of $258.83, for a total value of $2,588,300.00. Following the completion of the sale, the director now directly owns 77,172 shares of the company’s stock, valued at $19,974,428.76. The disclosure for this sale can be found here. Insiders sold a total of 86,603 shares of company stock valued at $22,837,660 over the last three months. 0.87% of the stock is currently owned by insiders.

Shares of NYSE:UNH opened at $265.49 on Friday. The company has a market cap of $252.81 billion, a PE ratio of 22.98, a PEG ratio of 1.56 and a beta of 0.71. UnitedHealth Group Inc has a twelve month low of $186.00 and a twelve month high of $271.16. The company has a current ratio of 0.75, a quick ratio of 0.75 and a debt-to-equity ratio of 0.63.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 17th. The healthcare conglomerate reported $3.14 EPS for the quarter, beating analysts’ consensus estimates of $3.04 by $0.10. The business had revenue of $56.09 billion during the quarter, compared to analyst estimates of $56.10 billion. UnitedHealth Group had a return on equity of 22.79% and a net margin of 5.55%. UnitedHealth Group’s quarterly revenue was up 12.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.46 EPS. equities analysts predict that UnitedHealth Group Inc will post 12.72 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 18th. Investors of record on Friday, September 7th will be given a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a yield of 1.36%. The ex-dividend date of this dividend is Thursday, September 6th. UnitedHealth Group’s payout ratio is currently 35.75%.

UnitedHealth Group announced that its board has approved a share repurchase plan on Wednesday, June 6th that authorizes the company to repurchase 100,000,000 shares. This repurchase authorization authorizes the healthcare conglomerate to repurchase shares of its stock through open market purchases. Shares repurchase plans are often a sign that the company’s management believes its stock is undervalued.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

See Also: Marijuana Stocks Future Looks Bright

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.